Dr. Unger has founded three biotech companies. His first, ImaRx Pharmaceutical, developed 3 FDA approved drugs and was acquired by DuPont yielding a > 20x ROI. Dr. Unger’s second company, ImaRx Therapeutics, went public and performed clinical trials with a technology to treat stroke. Dr. Unger co-founded NuvOx. He is inventor on 113 issued US patents, a board-certified radiologist and professor of radiology and BME at the University of Arizona.

Dr. Jennifer Johnson is a co-founder of NuvOx. She brings more than 20 years of deep R&D and regulatory experiences. Dr. Johnson specializes in pharmacokinetics, formulation, biostatistics, and project management. She is an award-winning scientist, inventor on multiple US patents, and author for numerous publications for prestigious scientific journals.

Rong was trained as an engineer and received an MBA from University of Michigan. She has more than 20 years’ experiences in finance, operation, and business development, serving both public and private companies. She is passionate about the biotech/life science industry because of the noble causes and complexities. Excited by its impactful science and technology, Rong joined NuvOx to focus on both operation and finance.